This site is intended for healthcare professionals
Psoriasis Academy

Expert Opinion

Read time: 45 mins
Last updated:22nd Mar 2022
Published:26th Oct 2021

Join Professors Stefano Piaserico, Ulrich Mrowietz, and Jordi Quoidbach, as they share the latest insights regarding the mind-body connection in psoriasis treatment. Discover:

  • The impact of psoriasis on wellbeing and happiness
  • Assessing and measuring wellbeing outcomes in psoriasis
  • Recommended practice changes to improve psoriasis treatment

This content is from the Almirall-sponsored symposium ‘Are you wasting your time getting to PASI 100? Come and listen to the brain fight with the skin!’, presented at the EADV Virtual Congress 2021 - created with expert faculty. This content describes the POSITIVE study, and is intended for health care professionals only.

Watch highlights from the Almirall-sponsored symposium ‘Are you wasting your time getting to PASI 100? Come and listen to the brain fight with the skin!’, presented at the European Academy of Dermatology and Venereology (EADV) Virtual Congress 2021.

Meet Professors Jordi Quoidbach, Stefano Piaserico, and Ulrich Mrowietz

How should Psoriasis Area and Severity Index 100 be measured in clinical practice, and what treatment can achieve PASI 100?

Does short-term psoriasis treatment improve patient wellbeing?

How does the Dermatology Life Quality Index (DLQI) relate to wellbeing and PASI in people with psoriasis?

What is the impact of psoriasis on patient happiness and wellbeing?

What is the relationship between psoriasis, happiness, and inflammation?

How effective is cognitive behavioural therapy (CBT) in psoriasis treatment?

How do busy clinicians incorporate wellbeing patient surveys into psoriasis consultations?

What is the POSITIVE study, and why is it important for people with psoriasis?

Why was tildrakizumab evaluated for treating psoriasis in the POSITIVE study?


These expert videos explore the pathogenesis of psoriasis, and the role of stress in psoriasis progression. They highlight the impact of psoriasis on patient wellbeing and happiness, if PASI 100 is the optimal treatment goal from a patient perspective, and the interplay between emotion, the psoriasis inflammatory response, and recovery.

Using a simple wellbeing patient survey in consultations may significantly improve the quality of life and happiness of people with psoriasis.

Meet the Experts

Piaserico 200 px.pngProfessor Stefano Piaserico

Professor Stefano Piaserico is an Associate Professor at the University of Padua, Italy, and Head of the Regional Centre for Psoriasis. He qualified in Medicine and Surgery in 1997 from the University of Padua, and was awarded a PhD in Biochemistry and Biophysics. He conducted research also at the Regional Centre for Melanoma at Istituto Oncologico Veneto (IOV) in Italy.

His research is mainly based in dermatology and venereology with a key focus on psoriasis, psoriatic arthritis, organ transplant recipients, photodynamic therapy, and skin cancer. He has built up a wide portfolio of more than 160 publications in several scientific journals. He is an associate of numerous professional organisations, including the Italian Society of Dermatology and the European Academy of Dermatology and Venereology (EADV).


Professor Jordi Quoidbach.pngProfessor Jordi Quoidbach

Professor Jordi Quoidbach is an Associate Professor in the Department of People Management and Organizations at ESADE Business School in Barcelona. He completed his PhD in Psychology at the University of Liège, before spending several years as a Postdoctoral Fellow at Harvard University. Professor Quoidbach is an expert in emotions, wellbeing and decision-making, has published popular science books on emotions and wellbeing, and hosted a TEDx talk on happiness as well as a TV series about the Science of Happiness on the French television channel M6. His research features novel perspectives for increasing happiness and helping individuals make better personal and professional decisions, and has been published in journals such as Science, PNAS, Nature Communications, and JAMA: Psychiatry. Popular accounts of Professor Quoidbach's research have been featured on popular media such as CNN, BBC, the Wall Street Journal, and the New York Times. He was identified among the Best 40 Business Professors Under 40 in Poets & Quants.


Professor Ulrich Mrowietz.pngProfessor Ulrich Mrowietz

Ulrich Mrowietz is Professor of Dermatology and founder of the Psoriasis-Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. His main research areas in psoriasis include management strategies, drug development, and basic research. The Psoriasis-Center provides a large clinical trial unit, and is part of the Comprehensive Center for Inflammation Medicine at the Kiel Campus. Professor Mrowietz is author or co-author of more than 358 peer-reviewed publications listed in the Medline database, and numerous other publications in the field. His h-Index is 61. In addition, he is author of psoriasis textbook chapters in Braun-Falco’s Dermatology and Venerology and other textbooks. From 2004–2019 Professor Mrowietz was the Editor-in-Chief of Archives of Dermatological Research. He is a former member of the Executive Board of the German Dermatological Society. Professor Mrowietz is also councillor of the International Psoriasis Council, member of the scientific advisory board of the German Psoriasis Association, the Clusters of Excellence ‘Inflammation at Interfaces’ and ‘Precision Medicine in Chronic Inflammation’ , and of numerous dermatological societies. Professor Mrowietz was the president of the 6th World Psoriasis and Psoriatic Arthritis Conference in July 2021 in Stockholm, Sweden.